572 related articles for article (PubMed ID: 20869780)
1. The sigma-1 receptor chaperone as an inter-organelle signaling modulator.
Su TP; Hayashi T; Maurice T; Buch S; Ruoho AE
Trends Pharmacol Sci; 2010 Dec; 31(12):557-66. PubMed ID: 20869780
[TBL] [Abstract][Full Text] [Related]
2. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.
Hayashi T; Su TP
Cell; 2007 Nov; 131(3):596-610. PubMed ID: 17981125
[TBL] [Abstract][Full Text] [Related]
3. Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival.
Mori T; Hayashi T; Hayashi E; Su TP
PLoS One; 2013; 8(10):e76941. PubMed ID: 24204710
[TBL] [Abstract][Full Text] [Related]
4. The sigma-1 receptor: roles in neuronal plasticity and disease.
Kourrich S; Su TP; Fujimoto M; Bonci A
Trends Neurosci; 2012 Dec; 35(12):762-71. PubMed ID: 23102998
[TBL] [Abstract][Full Text] [Related]
5. The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.
Penke B; Fulop L; Szucs M; Frecska E
Curr Neuropharmacol; 2018; 16(1):97-116. PubMed ID: 28554311
[TBL] [Abstract][Full Text] [Related]
6. Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction.
Hayashi T; Fujimoto M
Mol Pharmacol; 2010 Apr; 77(4):517-28. PubMed ID: 20053954
[TBL] [Abstract][Full Text] [Related]
7. Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway.
Tsai SY; Hayashi T; Harvey BK; Wang Y; Wu WW; Shen RF; Zhang Y; Becker KG; Hoffer BJ; Su TP
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22468-73. PubMed ID: 20018732
[TBL] [Abstract][Full Text] [Related]
8. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases.
Weng TY; Tsai SA; Su TP
J Biomed Sci; 2017 Sep; 24(1):74. PubMed ID: 28917260
[TBL] [Abstract][Full Text] [Related]
9. The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.
Su TP; Su TC; Nakamura Y; Tsai SY
Trends Pharmacol Sci; 2016 Apr; 37(4):262-278. PubMed ID: 26869505
[TBL] [Abstract][Full Text] [Related]
10. Sigma-1 Receptors Fine-Tune the Neuronal Networks.
Tsai SA; Su TP
Adv Exp Med Biol; 2017; 964():79-83. PubMed ID: 28315266
[TBL] [Abstract][Full Text] [Related]
11. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor.
Fujimoto M; Hayashi T; Urfer R; Mita S; Su TP
Synapse; 2012 Jul; 66(7):630-9. PubMed ID: 22337473
[TBL] [Abstract][Full Text] [Related]
12. Sigma-1 receptor: the novel intracellular target of neuropsychotherapeutic drugs.
Hayashi T
J Pharmacol Sci; 2015 Jan; 127(1):2-5. PubMed ID: 25704011
[TBL] [Abstract][Full Text] [Related]
13. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB.
Meunier J; Hayashi T
J Pharmacol Exp Ther; 2010 Feb; 332(2):388-97. PubMed ID: 19855099
[TBL] [Abstract][Full Text] [Related]
14. Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain.
Wang SM; Goguadze N; Kimura Y; Yasui Y; Pan B; Wang TY; Nakamura Y; Lin YT; Hogan QH; Wilson KL; Su TP; Wu HE
Mol Neurobiol; 2021 Jun; 58(6):2523-2541. PubMed ID: 33459966
[TBL] [Abstract][Full Text] [Related]
15. Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope.
Tsai SY; Chuang JY; Tsai MS; Wang XF; Xi ZX; Hung JJ; Chang WC; Bonci A; Su TP
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6562-70. PubMed ID: 26554014
[TBL] [Abstract][Full Text] [Related]
16. Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.
Tsai SY; Pokrass MJ; Klauer NR; De Credico NE; Su TP
Expert Opin Ther Targets; 2014 Dec; 18(12):1461-76. PubMed ID: 25331742
[TBL] [Abstract][Full Text] [Related]
17. MAM: more than just a housekeeper.
Hayashi T; Rizzuto R; Hajnoczky G; Su TP
Trends Cell Biol; 2009 Feb; 19(2):81-8. PubMed ID: 19144519
[TBL] [Abstract][Full Text] [Related]
18. N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk.
Cheng D; Lei ZG; Chu K; Lam OJH; Chiang CY; Zhang ZJ
Alzheimers Res Ther; 2024 May; 16(1):95. PubMed ID: 38693554
[TBL] [Abstract][Full Text] [Related]
19. Compromising σ-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-κB/Bcl-2-dependent mechanism: potential relevance to Parkinson's disease.
Mori T; Hayashi T; Su TP
J Pharmacol Exp Ther; 2012 Jun; 341(3):663-71. PubMed ID: 22399814
[TBL] [Abstract][Full Text] [Related]
20. The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration.
Ruscher K; Wieloch T
J Pharmacol Sci; 2015 Jan; 127(1):30-5. PubMed ID: 25704015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
